Last reviewed · How we verify

Peppermint sweets — Competitive Intelligence Brief

Peppermint sweets (Peppermint sweets) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Consumer Health / Symptomatic Relief.

phase 3 TRPM8 receptor Consumer Health / Symptomatic Relief Small molecule Live · refreshed every 30 min

Target snapshot

Peppermint sweets (Peppermint sweets) — St. Antonius Hospital. Peppermint sweets provide symptomatic relief through the cooling and soothing properties of menthol, which activates TRPM8 receptors to produce a refreshing sensation in the oral cavity and throat.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Peppermint sweets TARGET Peppermint sweets St. Antonius Hospital phase 3 TRPM8 receptor
Angal, lozenges [menthol], Angal, lozenges [menthol], Sandoz phase 3 Topical analgesic/local anesthetic TRPM8 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Peppermint sweets — Competitive Intelligence Brief. https://druglandscape.com/ci/peppermint-sweets. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: